Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Zai Lab Limited ADR (NASDAQ: ZLAB) was $25.32 for the day, down -0.35% from the previous closing price of $25.41. In other words, the price has decreased by -$0.35 from its previous closing price. On the day, 0.99 million shares were traded. ZLAB stock price reached its highest trading level at $25.65 during the session, while it also had its lowest trading level at $25.13.
Ratios:
Our analysis of ZLAB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.93 and its Current Ratio is at 3.12. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.01.
On March 07, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $55.
BofA Securities Downgraded its Buy to Neutral on March 03, 2025, whereas the target price for the stock was revised from $29 to $36.10.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 02 ’25 when Chen Yajing sold 456 shares for $34.25 per share. The transaction valued at 15,617 led to the insider holds 17,184 shares of the business.
Chen Yajing bought 456 shares of ZLAB for $15,617 on Oct 02 ’25. On Sep 10 ’25, another insider, Smiley Joshua L, who serves as the insider of the company, bought 10,000 shares for $28.91 each. As a result, the insider paid 289,100 and bolstered with 86,604 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 2916331520 and an Enterprise Value of 27300032512. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.59 while its Price-to-Book (P/B) ratio in mrq is 3.51. Its current Enterprise Value per Revenue stands at 63.815 whereas that against EBITDA is -116.74.
Stock Price History:
The Beta on a monthly basis for ZLAB is 1.05, which has changed by -0.1621443 over the last 52 weeks, in comparison to a change of 0.20772064 over the same period for the S&P500. Over the past 52 weeks, ZLAB has reached a high of $44.34, while it has fallen to a 52-week low of $23.82. The 50-Day Moving Average of the stock is -19.43%, while the 200-Day Moving Average is calculated to be -22.59%.
Shares Statistics:
ZLAB traded an average of 707.36K shares per day over the past three months and 922520 shares per day over the past ten days. A total of 109.91M shares are outstanding, with a floating share count of 109.00M. Insiders hold about 2.04% of the company’s shares, while institutions hold 37.43% stake in the company. Shares short for ZLAB as of 1760486400 were 4811176 with a Short Ratio of 6.80, compared to 1757894400 on 4882056. Therefore, it implies a Short% of Shares Outstanding of 4811176 and a Short% of Float of 4.9000002.
Earnings Estimates
The market rating of Zai Lab Limited ADR (ZLAB) is currently shaped by the ongoing analysis conducted by 6.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.13, with high estimates of $0.08 and low estimates of -$0.47.
Analysts are recommending an EPS of between -$1.06 and -$1.78 for the fiscal current year, implying an average EPS of -$1.4. EPS for the following year is $0.25, with 10.0 analysts recommending between $0.8 and -$0.33.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 8 analysts. It ranges from a high estimate of $157.9M to a low estimate of $130.38M. As of. The current estimate, Zai Lab Limited ADR’s year-ago sales were $102.27MFor the next quarter, 8 analysts are estimating revenue of $185.1M. There is a high estimate of $218.71M for the next quarter, whereas the lowest estimate is $156.6M.
A total of 17 analysts have provided revenue estimates for ZLAB’s current fiscal year. The highest revenue estimate was $579M, while the lowest revenue estimate was $508.7M, resulting in an average revenue estimate of $556.41M. In the same quarter a year ago, actual revenue was $398.99MBased on 16 analysts’ estimates, the company’s revenue will be $844.18M in the next fiscal year. The high estimate is $962M and the low estimate is $704.23M.
